Palladium-catalyzed cross-coupling reactions for the synthesis of 6, 8-disubstituted 1, 7-naphthyridines: a novel class of potent and selective phosphodiesterase type …

R Hersperger, K Bray-French, L Mazzoni…

Index: Journal of Medicinal Chemistry, , vol. 43, # 4 p. 675 - 682

Full Text: HTML

Citation Number: 48

Abstract

... Journal of Medicinal Chemistry. ... 1,2 Originally fuelled mainly by preclinical findings, this approach has received substantial support from recent clinical studies, and the search for novel PDE4 inhibitors is currently one of the most active fields in the pharmaceutical industry. ...

Related Articles:

Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4)

[Day, Jonathan P.; Lindsay, Barbara; Riddell, Tracy; Jiang, Zhong; Allcock, Robert W.; Abraham, Achamma; Sookup, Sebastian; Christian, Frank; Bogum, Jana; Martin, Elisabeth K.; Rae, Robert L.; Anthony, Diana; Rosair, Georgina M.; Houslay, Daniel M.; Huston, Elaine; Baillie, George S.; Klussmann, Enno; Houslay, Miles D.; Adams, David R. Journal of Medicinal Chemistry, 2011 , vol. 54, # 9 p. 3331 - 3347]

A scalable synthesis of a 1, 7-naphthyridine derivative, a PDE-4 inhibitor

[Organic Process Research and Development, , vol. 14, # 4 p. 883 - 889]

Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure–activity relationships of a series of quinoline and …

[Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4735 - 4751]

Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure–activity relationships of a series of quinoline and …

[Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4735 - 4751]

More Articles...